KORTUC Phase II – Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
Condition(s):Breast CancerLast Updated:March 4, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:March 4, 2024Recruiting
Condition(s):Breast CancerLast Updated:June 21, 2022Completed
Condition(s):Breast Cancer; RecurrentLast Updated:April 7, 2023Recruiting
Condition(s):Survival RateLast Updated:February 14, 2017Completed
Condition(s):Breast CancerLast Updated:October 24, 2011Terminated
Condition(s):Breast NeoplasmsLast Updated:May 29, 2015Completed
Condition(s):Breast CancerLast Updated:March 22, 2016Terminated
Condition(s):Breast Neoplasms; TamoxifenLast Updated:October 14, 2009Completed
Condition(s):Recurrent Breast CancerLast Updated:March 25, 2024Recruiting
Condition(s):Breast CancerLast Updated:December 24, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.